| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/31/2007 | WO2007060725A1 Recombinant polyvalent vaccine |
| 05/31/2007 | WO2007060618A2 Macrolides derivatives as antibacterial agents |
| 05/31/2007 | WO2007060419A2 Method of preventing oral staining |
| 05/31/2007 | WO2007060413A1 Treatment of sub-gingival pocket infections |
| 05/31/2007 | WO2007060253A1 Substituted aminophenylsulfonamide compounds as hiv protease inhibitor |
| 05/31/2007 | WO2007060249A1 Aminophenylsulfonamide derivatives as hiv protease inhibitor |
| 05/31/2007 | WO2007060028A1 Napthyridine compounds as rock inhibitors |
| 05/31/2007 | WO2007059908A1 Novel cyclic iminopeptide derivatives and a process for preparing cyclic iminopeptide derivatives |
| 05/31/2007 | WO2007059685A1 Astragalus calycosin with the function of resisting coxackievirus |
| 05/31/2007 | WO2007059625A1 Bacterial antigens and uses thereof |
| 05/31/2007 | WO2007037518A9 Mutilin derivative and pharmaceutical composition containing the same |
| 05/31/2007 | WO2007031520A3 Use of octenidine dihydrochloride in semisolid preparations |
| 05/31/2007 | WO2007031519A3 Antimicrobial preparations having a content of octenidine dihydrochloride encapsulated in liposomes |
| 05/31/2007 | WO2007027323A3 TRICYCLIC 6-ALKYLIDENE-PENEM β-LACTAMASE INHIBITORS AND β-LACTAM ANTIBIOTIC COMBINATION: A BROAD SPECTRUM ANTIBIOTIC |
| 05/31/2007 | WO2007025276A3 Use of hiv envelope/ cd4 complexes as immunogenic complexes for the generation of antibodies |
| 05/31/2007 | WO2007020382A3 Plant-based medicament for the treatment of liver disease |
| 05/31/2007 | WO2007014941A8 Quinoline derivatives as antibacterial agents |
| 05/31/2007 | WO2007014469A8 Hepatitis c antivirals |
| 05/31/2007 | WO2007014393A3 Amorphous efavirenz and the production thereof |
| 05/31/2007 | WO2007003957A3 Steroidal glycoside compounds as core 2 glcnac- t inhibitors |
| 05/31/2007 | WO2007000343A3 Process for manufacturing vaccines |
| 05/31/2007 | WO2007000342A3 Immunogenic composition |
| 05/31/2007 | WO2007000314A3 Immunogenic composition |
| 05/31/2007 | WO2006084056A3 Compounds and methods for modulating communication and virulence in quorum sensing bacteria |
| 05/31/2007 | WO2006042418A9 Antiviral oligonucleotides |
| 05/31/2007 | WO2002094185A3 Conjugates and compositions for cellular delivery |
| 05/31/2007 | US20070124837 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 05/31/2007 | US20070123566 Isoflavone derivatives of tectoridin, the preparation thereof and the anti-virus medicines containing the same as an effective constituents |
| 05/31/2007 | US20070123530 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases |
| 05/31/2007 | US20070123524 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; inhibitors of HIV replication; with other HIV/AIDS antivirals, anti-infectives, immunomodulators, antibiotics or vaccines; AIDS |
| 05/31/2007 | US20070123459 IL-17 like molecules and uses thereof |
| 05/31/2007 | US20070122424 Peptide-based vaccine for influenza |
| 05/31/2007 | US20070122416 Cross-reactive displacing antibodies from collagen-binding proteins and method of identification and use |
| 05/31/2007 | US20070122403 Molecules with extended half-lives, compositions and uses thereof |
| 05/31/2007 | US20070122381 Method for regulating neuron development and maintenance |
| 05/31/2007 | CA2631241A1 Materials and methods for treating viral infections with a cysteamine compound |
| 05/31/2007 | CA2630770A1 Recombinant polyvalent vaccine |
| 05/31/2007 | CA2630738A1 Immunostimulatory oligoribonucleotides |
| 05/31/2007 | CA2630404A1 Method for de-esterification of the lipopolysaccharide layer of neisseria meningitidis and mannheimia haemolytica |
| 05/31/2007 | CA2628542A1 Substituted aminophenylsulfonamide compounds as hiv protease inhibitor |
| 05/31/2007 | CA2628540A1 Aminophenylsulfonamide derivatives as hiv protease inhibitor |
| 05/31/2007 | CA2593718A1 Napthyridine compounds as rock inhibitors |
| 05/30/2007 | EP1790983A1 Method of screening compound preventing cells from infection with hepatitis c virus (hcv) |
| 05/30/2007 | EP1790730A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/30/2007 | EP1790729A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/30/2007 | EP1790725A2 Proteins named after FCTRX and nucleic acids encoding same |
| 05/30/2007 | EP1790687A2 Cereal beta glucan compositions, methods of preparation and uses thereof |
| 05/30/2007 | EP1790659A2 Polypeptides of pseudomonas aeruginosa |
| 05/30/2007 | EP1790658A2 Anti-viral vectors |
| 05/30/2007 | EP1790655A2 Biologically active peptides |
| 05/30/2007 | EP1790642A1 Biologically active methylene blue derivatives |
| 05/30/2007 | EP1790639A1 Compound containing basic group and use thereof |
| 05/30/2007 | EP1790638A1 Carbamoylpyridone derivative having hiv integrase inhibitory activity |
| 05/30/2007 | EP1790637A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| 05/30/2007 | EP1789419A1 Gyrase inhibitors and uses thereof |
| 05/30/2007 | EP1789139A1 Fumarate of 4-((4-((4-(2-cyanoethenyl)-2,6-dimethylphenyl|amino|-2-pyrimidinyl|amino|benzonitrile |
| 05/30/2007 | EP1789065A2 Biologically active composition |
| 05/30/2007 | EP1789056A1 Use of steroid-derived pharmaceutical compositions for treating disorders relating to pathological processes in lipid rafts |
| 05/30/2007 | EP1789047A2 Treatment of diseases using nalmefene and its analgos |
| 05/30/2007 | EP1789043A2 Compositions and methods for treating or preventing hepadnaviridae infection |
| 05/30/2007 | EP1789042A2 1-alkoxy 1h-imidazo ring systems and methods |
| 05/30/2007 | EP1789040A2 Halogenated benzamide derivatives |
| 05/30/2007 | EP1789039A2 S-triazolyl alpha -mercaptoacetanildes as inhibitors of hiv reverse transcriptase |
| 05/30/2007 | EP1538888A4 Upper hitch link |
| 05/30/2007 | EP1450767B1 Microspherules containing a pleuromutilin derivative |
| 05/30/2007 | EP1318814B1 Triazole compounds useful as protein kinase inhibitors |
| 05/30/2007 | EP1263482A4 Apparatus and method of treatment of wounds, burns and immune system disorders |
| 05/30/2007 | EP1177168B1 Caspase inhibitors and the use thereof |
| 05/30/2007 | EP1019010B1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 05/30/2007 | EP0692974B2 Multicomponent clostridial vaccines using saponin adjuvants |
| 05/30/2007 | CN1973030A Dendritic cell obtained by antigen pulsing |
| 05/30/2007 | CN1972694A Antibiotics containing borinic acid complexes and methods of use |
| 05/30/2007 | CN1972683A Composition comprising lactic acid and lactoferrin |
| 05/30/2007 | CN1972604A Improvement of barrier integrity in HIV patients |
| 05/30/2007 | CN1970774A Porcine alpha-interferon recombinant adenovirus and its construction method and application |
| 05/30/2007 | CN1970764A Porcine beta-interferon recombinant adenovirus and its construction method and application |
| 05/30/2007 | CN1970572A Interferon alpha mutant and its polyethylene glycol derivative |
| 05/30/2007 | CN1970570A Yeast engineered bacteria for expressing recombinant prawn protein Pen9 and its preparation method and uses |
| 05/30/2007 | CN1970561A Cefoperazone sodium novel crystal form and its preparation method |
| 05/30/2007 | CN1970559A Beta-carboline alkaloid, their preparation method and use |
| 05/30/2007 | CN1970556A 1-furfuryl-3-substituted Indolinyl-2-one derivative, its preparation method and uses |
| 05/30/2007 | CN1970552A Substituted[1,3,5] triazine compound, its preparing process and its application |
| 05/30/2007 | CN1970526A Bromo nitryl dihydroxy diphenyl ether compound and its synthesis method |
| 05/30/2007 | CN1970082A Preparation process of autogenous high-immunity serum for treating post-weaning multi systemic wasting syndrome of baby pig |
| 05/30/2007 | CN1970081A Avian influenza virus marking vaccine, preparation process and application thereof |
| 05/30/2007 | CN1970080A Method for producing virus vaccine by using suspended Vero cell |
| 05/30/2007 | CN1970076A Method for preparing colon targeted pill of polymyxin B sulfate used for poultry and livestock |
| 05/30/2007 | CN1970056A Taste improved 'Xin Xue' powder |
| 05/30/2007 | CN1970052A Medicinal powder for treating parotitis of teenagers |
| 05/30/2007 | CN1970033A Pharmaceutical composition for treating bacterial infection of milched cow, preparation process and use thereof |
| 05/30/2007 | CN1970030A Chinese medicine for treating rheumatoid arthritis, preparation method and application thereof |
| 05/30/2007 | CN1970029A Medicament for treating onychomycosis |
| 05/30/2007 | CN1970020A A pharmaceutical composition, preparation process and application thereof |
| 05/30/2007 | CN1970014A Chinese medicinal powder or lotion for treating dermatomycosis and method for preparing same |
| 05/30/2007 | CN1970001A Pharmaceutical composition comprising kurarinone, magnolia vine fruit and ginseng for treating hepatitis |
| 05/30/2007 | CN1970000A Antivirus Chinese medicinal formulation, preparation process, quality control method and application thereof |
| 05/30/2007 | CN1969997A Antivirus compound formulation, preparation process, quality control method and use thereof |
| 05/30/2007 | CN1969994A Powder for treating beriberi |
| 05/30/2007 | CN1969963A Method for extracting medicament effective component for treating hepatitis and medicinal composition thereof |
| 05/30/2007 | CN1969958A Quality control method of an oral formulation for treating viral hepatitis |